These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 17424907

  • 1. Mitochondrial Abeta: a potential cause of metabolic dysfunction in Alzheimer's disease.
    Chen X, Yan SD.
    IUBMB Life; 2006 Dec; 58(12):686-94. PubMed ID: 17424907
    [Abstract] [Full Text] [Related]

  • 2. Pathogenic role of mitochondrial [correction of mitochondral] amyloid-beta peptide.
    Chen JX, Yan SD.
    Expert Rev Neurother; 2007 Nov; 7(11):1517-25. PubMed ID: 17997700
    [Abstract] [Full Text] [Related]

  • 3. Role of mitochondrial amyloid-beta in Alzheimer's disease.
    Chen JX, Yan SS.
    J Alzheimers Dis; 2010 Nov; 20 Suppl 2():S569-78. PubMed ID: 20463403
    [Abstract] [Full Text] [Related]

  • 4. ABAD enhances Abeta-induced cell stress via mitochondrial dysfunction.
    Takuma K, Yao J, Huang J, Xu H, Chen X, Luddy J, Trillat AC, Stern DM, Arancio O, Yan SS.
    FASEB J; 2005 Apr; 19(6):597-8. PubMed ID: 15665036
    [Abstract] [Full Text] [Related]

  • 5. The consequences of mitochondrial amyloid beta-peptide in Alzheimer's disease.
    Muirhead KE, Borger E, Aitken L, Conway SJ, Gunn-Moore FJ.
    Biochem J; 2010 Feb 24; 426(3):255-70. PubMed ID: 20175748
    [Abstract] [Full Text] [Related]

  • 6. Mechanisms of mitochondrial dysfunction and energy deficiency in Alzheimer's disease.
    Atamna H, Frey WH.
    Mitochondrion; 2007 Sep 24; 7(5):297-310. PubMed ID: 17625988
    [Abstract] [Full Text] [Related]

  • 7. Mitochondrial β-amyloid in Alzheimer's disease.
    Borger E, Aitken L, Muirhead KE, Allen ZE, Ainge JA, Conway SJ, Gunn-Moore FJ.
    Biochem Soc Trans; 2011 Aug 24; 39(4):868-73. PubMed ID: 21787315
    [Abstract] [Full Text] [Related]

  • 8. Mitochondria dysfunction of Alzheimer's disease cybrids enhances Abeta toxicity.
    Cardoso SM, Santana I, Swerdlow RH, Oliveira CR.
    J Neurochem; 2004 Jun 24; 89(6):1417-26. PubMed ID: 15189344
    [Abstract] [Full Text] [Related]

  • 9. Mitochondrial dysfunction: an early event in Alzheimer pathology accumulates with age in AD transgenic mice.
    Hauptmann S, Scherping I, Dröse S, Brandt U, Schulz KL, Jendrach M, Leuner K, Eckert A, Müller WE.
    Neurobiol Aging; 2009 Oct 24; 30(10):1574-86. PubMed ID: 18295378
    [Abstract] [Full Text] [Related]

  • 10. Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease.
    Caspersen C, Wang N, Yao J, Sosunov A, Chen X, Lustbader JW, Xu HW, Stern D, McKhann G, Yan SD.
    FASEB J; 2005 Dec 24; 19(14):2040-1. PubMed ID: 16210396
    [Abstract] [Full Text] [Related]

  • 11. [Mitochondrial enzyme ABAD and its role in the development and treatment of Alzheimer's disease].
    Benek O, Musílek K, Kuca K.
    Ceska Slov Farm; 2012 Aug 24; 61(4):144-9. PubMed ID: 23251955
    [Abstract] [Full Text] [Related]

  • 12. Amyloid precursor protein and mitochondrial dysfunction in Alzheimer's disease.
    Anandatheerthavarada HK, Devi L.
    Neuroscientist; 2007 Dec 24; 13(6):626-38. PubMed ID: 17911214
    [Abstract] [Full Text] [Related]

  • 13. Identification of small-molecule inhibitors of the Abeta-ABAD interaction.
    Xie Y, Deng S, Chen Z, Yan S, Landry DW.
    Bioorg Med Chem Lett; 2006 Sep 01; 16(17):4657-60. PubMed ID: 16781151
    [Abstract] [Full Text] [Related]

  • 14. Cytoprotective role of mitochondrial amyloid beta peptide-binding alcohol dehydrogenase against a cytotoxic aldehyde.
    Murakami Y, Ohsawa I, Kasahara T, Ohta S.
    Neurobiol Aging; 2009 Feb 01; 30(2):325-9. PubMed ID: 17707551
    [Abstract] [Full Text] [Related]

  • 15. Amyloid-beta precursor protein mediates neuronal toxicity of amyloid beta through Go protein activation.
    Sola Vigo F, Kedikian G, Heredia L, Heredia F, Añel AD, Rosa AL, Lorenzo A.
    Neurobiol Aging; 2009 Sep 01; 30(9):1379-92. PubMed ID: 18187234
    [Abstract] [Full Text] [Related]

  • 16. Insights into amyloid-beta-induced mitochondrial dysfunction in Alzheimer disease.
    Wang X, Su B, Perry G, Smith MA, Zhu X.
    Free Radic Biol Med; 2007 Dec 15; 43(12):1569-73. PubMed ID: 18037122
    [Abstract] [Full Text] [Related]

  • 17. A "mitochondrial cascade hypothesis" for sporadic Alzheimer's disease.
    Swerdlow RH, Khan SM.
    Med Hypotheses; 2004 Dec 15; 63(1):8-20. PubMed ID: 15193340
    [Abstract] [Full Text] [Related]

  • 18. Soluble beta-amyloid leads to mitochondrial defects in amyloid precursor protein and tau transgenic mice.
    Eckert A, Hauptmann S, Scherping I, Rhein V, Müller-Spahn F, Götz J, Müller WE.
    Neurodegener Dis; 2008 Dec 15; 5(3-4):157-9. PubMed ID: 18322377
    [Abstract] [Full Text] [Related]

  • 19. Melatonin treatment restores mitochondrial function in Alzheimer's mice: a mitochondrial protective role of melatonin membrane receptor signaling.
    Dragicevic N, Copes N, O'Neal-Moffitt G, Jin J, Buzzeo R, Mamcarz M, Tan J, Cao C, Olcese JM, Arendash GW, Bradshaw PC.
    J Pineal Res; 2011 Aug 15; 51(1):75-86. PubMed ID: 21355879
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of amyloid-beta (Abeta) peptide-binding alcohol dehydrogenase-Abeta interaction reduces Abeta accumulation and improves mitochondrial function in a mouse model of Alzheimer's disease.
    Yao J, Du H, Yan S, Fang F, Wang C, Lue LF, Guo L, Chen D, Stern DM, Gunn Moore FJ, Xi Chen J, Arancio O, Yan SS.
    J Neurosci; 2011 Feb 09; 31(6):2313-20. PubMed ID: 21307267
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.